Cheng‐long Huang

机构：Sun Yat-sen University, Maizuru Municipal Hospital, Sun Yat-sen University Cancer Center · ORCID：0009-0007-9019-0280

发表论文 88 篇 · 总被引 2904 次 · h-index 29

代表论文

• Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 73)
• Thyroid dose‐volume thresholds for the risk of radiation‐related hypothyroidism in nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy—A single‐institution study (2019 · Cancer Medicine · 被引 31)
• Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial (2025 · CA A Cancer Journal for Clinicians · 被引 26)
• Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial (2024 · Journal of Clinical Oncology · 被引 18)
• Downregulation of thymidylate synthase by RNAi molecules enhances the antitumor effect of pemetrexed in an orthotopic malignant mesothelioma xenograft mouse model (2016 · International Journal of Oncology · 被引 18)
• Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas (2025 · The Lancet Oncology · 被引 13)